Acknowledgement
This research was supported by the 2021 research year program funded by Jungwon University.
References
- L. J. Appel et al. (2003). Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA, 289(16), 2083-2093. DOI : 10.1001/jama.289.16.2083.
- J. P. Shrppard et al. (2020). Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPIMISER Randomized Clinical Trial. JAMA, 323(20), 2039-2051. DOI : 10.1001/jama.2020.4871.
- A. P. Somlyo & A. V. Somlyo. (1994). Signal transduction and regulation in smooth muscle. Nature, 372(6503), 231-236. DOI : 10.1038/372231a0.
- P. P. Khin, T. S. Zaw & U. D. Sohn. (2017). Signal Transduction Underlying the Inhibitory Mechanism of Floxetine on Electrical Field Stimulation Response in Rat Ileal Smooth Muscle. Pharmacology, 99(5-6), 216-225. DOI : 10.1159/000449528
- A. P. Somlyo & A. V. Somlyo. (1998). From pharmacomechanical coupling to G-proteins and myosin phosphatase. Acta Physiol Scand, 164(4), 437-448. DOI : 10.1046/j.1365-201X.1998.00454.x.
- K. P. Marconi, B. Bharathi, A. M. Venis, R. Raj, S. M. Amirtham & S. Subramani. (2020). Phenylephrine induces relaxation of longitudinal strips from small arteries of goat legs. PLoS One, 15(3), e0227316. DOI : 10.1371/journal.pone.0227316
- L. Yu, X. Jin, Y. Yang, N. Cui & C. Jiang. (2011). Rosiglitazone inhibits vascular KATP channels and coronary vasodilation produced by isoprenaline. Br J Pharmacol, 164(8), 2064-2072. DOI : 10.1111/j.1476-5381.2011.01539.x
- M. Uehata, T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa & S. Narumiya. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature, 389(6654), 990-994. DOI : 10.1038/40187
- S. Sakurada, N. Takuwa, N. Sugimoto, Y. Wang, M. Seto, Y. Sasaki & Y. Takuwa. (2003). Ca2+-dependent activation of Rho and Rho-kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res, 93(6), 548-556. DOI : 10.1161/01.RES.0000090998.08629.60
- T. Kitazawa, M. Masuo & A. P. Somlyo. (1991). G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA, 88(20), 9307-9310. DOI : 10.1073/pnas.88.20.9307
- A. Gohla, G. Schultz & S. Offermanns. (2000). Roles for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res, 87(3), 221-227. DOI : 10.1161/01.res.87.3.221.
- T. Leung, E. Manser, L. Tan & L. Lim. (1995). A novel serine/threonine kinase binding the Rasrelated RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem, 270(49), 29051-29054. DOI : 10.1074/jbc.270.49.29051
- T. Matsui et al. (1996). Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. The EMBO J, 15(9), 2208-2216. PMID: 8641286 https://doi.org/10.1002/j.1460-2075.1996.tb00574.x
- W. G. Wier & K. G. Morgan. (2003). Alpha1-adrenergic signaling mechanisms in contraction of resistance arteries. Rev Physiol Biochem Pharmacol, 150, 91-139. DOI : 10.1007/s10254-003-0019-8
- J. Niu et al. (2021). kappa-opioid receptor stimulation alleviates rat vascular smooth muscle cell calcification via PFKFB3-lactate signaling. Aging(Albany ny), 13(10), 14355-14371. DOI : 10.18632/aging.203050